Literature DB >> 21531673

Nurses' perceptions and experiences with end-of-life communication and care.

Denise Boyd1, Kristen Merkh, Dana N Rutledge, Victoria Randall.   

Abstract

PURPOSE/
OBJECTIVES: To characterize oncology nurses' attitudes toward care at the end of life (EOL) and their experiences in caring for terminally ill patients, hospice discussions with patients and families, and the use of palliative care practices.
DESIGN: Descriptive correlational survey study.
SETTING: A Magnet®-designated hospital in southern California with more than 500 beds. SAMPLE: 31 oncology nurses.
METHODS: Nurses completed the adapted version of the Caring for Terminally Ill Patients Nurse Survey. MAIN RESEARCH VARIABLES: Attitudes toward care at EOL and care experiences with terminally ill patients.
FINDINGS: Despite having fairly positive attitudes toward hospice and having discussions about prognosis with terminally ill patients, nurses reported missed opportunities for discussions and patient referrals to hospice. On average, nurses cared for more than seven terminally ill patients during a three-month period while only discussing hospice care with a third of these patients and their family members. Most nurses acknowledged that patients would benefit from earlier initiation of hospice care. Specific palliative care practices used by nurses in the past three months varied, with active and passive listening and requesting increased pain medications used most frequently and aromatherapy and guided imagery used least.
CONCLUSIONS: Missed opportunities may reflect nurses' attitudes. However, lack of patient and family member acceptance was the most important barrier to discussion of hospice. IMPLICATIONS FOR NURSING: Strategies to enable nurses to have a stronger voice during this critical time for their patients are needed and, when developed, supported in practice to ensure that they are used.

Entities:  

Mesh:

Year:  2011        PMID: 21531673     DOI: 10.1188/11.ONF.E229-E239

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  6 in total

1.  Advanced cancer patients' reported wishes at the end of life: a randomized controlled trial.

Authors:  Marvin O Delgado-Guay; Alfredo Rodriguez-Nunez; Vera De la Cruz; Susan Frisbee-Hume; Janet Williams; Jimin Wu; Diane Liu; Michael J Fisch; Eduardo Bruera
Journal:  Support Care Cancer       Date:  2016-05-10       Impact factor: 3.603

2.  Opportunity is the greatest barrier to providing palliative care to advanced colorectal cancer patients: a survey of oncology clinicians.

Authors:  M A Earp; A Sinnarajah; M Kerba; P A Tang; J Rodriguez-Arguello; S King; S M Watanabe; J E Simon
Journal:  Curr Oncol       Date:  2018-10-31       Impact factor: 3.677

3.  Path modeling of knowledge, attitude and practice toward palliative care consultation service among Taiwanese nursing staff: a cross-sectional study.

Authors:  Hsueh-Hsing Pan; Hsiu-Ling Shih; Li-Fen Wu; Yu-Chun Hung; Chi-Ming Chu; Kwua-Yun Wang
Journal:  BMC Palliat Care       Date:  2017-08-17       Impact factor: 3.234

4.  Associations among knowledge, attitudes, and practices toward palliative care consultation service in healthcare staffs: A cross-sectional study.

Authors:  Li-Chun Huang; Ho-Jui Tung; Pei-Chao Lin
Journal:  PLoS One       Date:  2019-10-11       Impact factor: 3.240

5.  Palliative care utilization in oncology and hemato-oncology: a systematic review of cognitive barriers and facilitators from the perspective of healthcare professionals, adult patients, and their families.

Authors:  Marco Bennardi; Nicola Diviani; Claudia Gamondi; Georg Stüssi; Piercarlo Saletti; Ivan Cinesi; Sara Rubinelli
Journal:  BMC Palliat Care       Date:  2020-04-13       Impact factor: 3.234

6.  The Effect of Practice toward Do-Not-Resuscitate among Taiwanese Nursing Staff Using Path Modeling.

Authors:  Li-Fen Wu; Li-Fang Chang; Yu-Chun Hung; Chin Lin; Shiow-Jyu Tzou; Lin-Ju Chou; Hsueh-Hsing Pan
Journal:  Int J Environ Res Public Health       Date:  2020-08-31       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.